Two studies of blood pressure (BP) elevation associated with pregnancy and the oral contraceptive

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN00582888

Enrollment

Registered

2003-09-12

Start date

2000-08-01

Completion date

Unknown

Last updated

2017-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular: Hypertension Circulatory System Hypertension

Interventions

Study 1 (controlled trial): 25 women who have developed significant BP elevation during pregnancy and 25 who have never suffered raised BP during pregnancy will receive combined oral contraceptives.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Study 1 - 25 women who have developed significant BP elevation and 25 who have never suffered raised BP during pregnancy. Study 2 - 50 women with a history of raised BP in association with taking oral contraceptive.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
First in a series of collaborative studies between CVSU, Obs & Gynae and Vascular Biology (Clin Pharm).	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026